πŸ‡ΊπŸ‡Έ FDA
Patent

US 8106006

Modified defensins and their use

granted A61KA61K38/1709A61P

Quick answer

US patent 8106006 (Modified defensins and their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/1709, A61P, A61P11/00, A61P11/06